Disease | lung cancer |
Phenotype | C0080032|malignant pleural effusions |
Sentences | 9 |
PubMedID- 25339042 | Prognostic values of vegf and endostatin with malignant pleural effusions in patients with lung cancer. |
PubMedID- 26125099 | Pleural effusion levels of dj-1 are increased in elderly lung cancer patients with malignant pleural effusions. |
PubMedID- 25798278 | Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancer. |
PubMedID- 24072496 | Interleukin 17 (il-17) has been found to be increased in some human cancers; however, the possible implication of il-17 in regulating antitumor responses in lung cancer patients with malignant pleural effusions (mpe) remains to be elucidated. |
PubMedID- 20207133 | A phase i clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions. |
PubMedID- 23533029 | In addition, the chemokine receptor ccr6 [which binds to the chemokine cc ligand 20 (ccl20) that is present in many malignant pleural effusions of lung cancer patients] is highly expressed on th17 cells thus further facilitating their recruitment to sites of tumor growth and inflammation (acosta-rodriguez et al., 2007; annunziato et al., 2007, 2012). |
PubMedID- 23243596 | The first one (nct00690261; current status: recruiting) specifically aims at investigating impact of m1/m2 macrophage polarization on cancer progression and prognosis prediction among lung cancer patients with malignant pleural effusions. |
PubMedID- 25621068 | Mmp-9 mrna expression levels in lymphocytes tended to be higher in malignant pleural effusions of lung cancer when compared with healthy pleural effusions (17). |
PubMedID- 23364973 | Diagnostic value and prognostic significance of pleural c-reactive protein in lung cancer patients with malignant pleural effusions. |
Page: 1